Dolutegravir Sodium Medications

Dolutegravir Sodium Info

What is Dolutegravir Sodium?

Dolutegravir sodium is an antiviral compound that belongs to the class of integrase strand-transfer inhibitors. It is designed to stop the HIV-1 virus from inserting its genetic material into human cells. In the United Kingdom, dolutegravir sodium is the active ingredient found in several prescription medicines used to manage HIV infection.

Medications with Dolutegravir Sodium

The most common product that contains dolutegravir sodium is the single-ingredient tablet simply called Dolutegravir. It is available in 50 mg tablets and is supplied as a generic medication. In addition, dolutegravir sodium is part of fixed-dose combination tablets such as Triumeq (dolutegravir + abacavir + lamivudine) and Dovato (dolutegravir + lamivudine). These combinations are marketed in the UK and are prescribed when a multifaceted treatment approach is needed. All of the preparations come as oral tablets; liquid formulations are not generally used for this ingredient in the UK.

What Does Dolutegravir Sodium Treat?

• HIV-1 infection (adults and adolescents) - Dolutegravir sodium is recommended as part of combination antiretroviral therapy to keep the virus at undetectable levels.
• Initial therapy for newly diagnosed patients - It can be used as a first-line option when starting treatment.
• Switch therapy for patients already on other regimens - Some clinicians may change a patient’s regimen to include dolutegravir sodium to simplify dosing or improve tolerability.

These are the primary indications approved by the Medicines and Healthcare products Regulatory Agency (MHRA). Use of dolutegravir sodium outside these settings would be considered off-label and should be discussed with a specialist.

How Dolutegravir Sodium Works

Dolutegravir sodium blocks the integrase enzyme, a tool the HIV virus needs to splice its DNA into the host’s genetic material. By preventing this step, the drug stops the virus from replicating and reduces the amount of virus in the blood. The effect begins within a few days of taking the medication, but full viral suppression may take several weeks.

Safety Information

Common Side Effects

• Mild headache or feeling tired.
• Nausea, occasional vomiting, or loose stools.
• Mild dizziness that usually resolves on its own.

These symptoms are generally short-lived and do not require medical intervention unless they persist.

Serious Reactions

• Rare allergic responses such as rash, swelling of the face, or difficulty breathing.
• Uncommon liver problems that may present as yellowing of the skin or dark urine.
• Sudden mood changes, including depression or suicidal thoughts, have been reported in isolated cases.

If any of these signs appear, seek immediate medical help.

Who Should Be Cautious

• Pregnancy - Dolutegravir sodium may be associated with a small increase in the risk of neural-tube defects when taken at the time of conception. Women who are pregnant or planning pregnancy should discuss alternatives with their clinician.
• Severe kidney impairment - The drug is eliminated partly by the kidneys, so reduced kidney function may require extra monitoring.
• Significant liver disease - Individuals with moderate to severe liver problems should be evaluated before starting therapy.

Interaction Awareness

• Other antiretrovirals - Dolutegravir sodium is often combined with other HIV medicines; certain combinations may affect blood levels of either drug.
• Metal cations - Antacids containing aluminium, magnesium, calcium, or iron can lower the absorption of dolutegravir sodium. Taking these products at separate times (at least two hours apart) helps avoid the interaction.
• Alcohol and recreational drugs - Heavy alcohol use does not directly affect the drug but can impair liver function and adherence to the regimen.

For a full list of possible interactions, refer to the specific product’s patient information leaflet.

What to Know Before Using

• Store tablets in a dry place at room temperature, protected from light.
• The medication is usually taken once daily, but the exact schedule may differ between the single-ingredient tablet and fixed-dose combinations.
• Treatment length can be lifelong; some patients may use dolutegravir sodium for a short period when switching regimens.
• Always follow the instructions printed on the medication’s packaging and any guidance given by the prescribing clinician.

For detailed usage, dosing, and administration, refer to the individual medication’s information.

Information Disclaimer

This article provides general educational information about dolutegravir sodium as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing dolutegravir sodium may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.